Cargando…
The role of moxifloxacin in tuberculosis therapy
Tuberculosis (TB) remains a global threat with more than 9 million new infections. Treatment remains difficult and there has been no change in the duration of the standard regimen since the early 1980s. Moreover, many patients are unable to tolerate this treatment and discontinue therapy, increasing...
Autor principal: | Gillespie, Stephen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487659/ https://www.ncbi.nlm.nih.gov/pubmed/26929417 http://dx.doi.org/10.1183/16000617.0085-2015 |
Ejemplares similares
-
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
por: Moodley, Riya, et al.
Publicado: (2016) -
Advances in target therapy in lung cancer
por: Sculier, Jean-Paul, et al.
Publicado: (2015) -
Vaccination at the forefront of the fight against hepatitis B and C
por: El-Sayed, Manal H., et al.
Publicado: (2021) -
Sleep apnoea
por: Jun, Jonathan C., et al.
Publicado: (2016) -
Paediatric respiratory infections
por: Everard, Mark L.
Publicado: (2016)